The appearance of blackcurrant compounds and the inhibition of MAO-B enzyme activity in blood after consuming a single dose of two different blackcurrant beverages in healthy adults
- Conditions
- MAO-B enzyme inhibitionNeurological - Studies of the normal brain and nervous system
- Registration Number
- ACTRN12624000929505
- Lead Sponsor
- Dr Jocelyn Eason - New Zealand Institute for Plant & Food Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 13
Healthy individual (male or female) 18 – 50 years who are able to provide written consent to participate when selected for this study, are non-smokers and vapers and have no strong reaction to giving blood samples will be selected for this study.
Participants will be excluded if they are unwilling to unable to provide written consent or comply with the study procedures. Participants will be excluded if they are pregnant, planning to get pregnant in the immediate future or have any of the following conditions: (i) blood borne diseases (e.g. hepatitis), (ii) recent bacterial or viral illness, (iii) are taking medication that affects the properties of blood (e.g. blood clotting) or immune function, (iv) are taking medication for mental health and mood disorders, (v) have a strong fear or dislike of needles and/or the sight of blood, have an aversion to blood sampling, or difficult veins to access.
Participants will be excluded if they have known hypersensitivity or intolerance to blackcurrants or blackcurrant derived foods.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method